| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689336 | European Urology | 2017 | 9 Pages |
Abstract
In this study of testicular cancer patients, we evaluated prognostic factors for outcome and calculated survival after standard chemotherapy. We find that survival has improved over the years and we propose new prognostic factors for outcome for validation in larger patient cohorts.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Maria G. Kier, Jakob Lauritsen, Mette S. Mortensen, Mikkel Bandak, Klaus K. Andersen, Merete K. Hansen, Mads Agerbaek, Niels V. Holm, Susanne O. Dalton, Christoffer Johansen, Gedske Daugaard,